{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:55:56Z","timestamp":1790675756924,"version":"4.1.0"},"publisher-location":"Berlin, Heidelberg","reference-count":140,"publisher":"Springer Berlin Heidelberg","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/164_2026_850","type":"book-chapter","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:01:36Z","timestamp":1790672496000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Carborane-Based Derivatives as Inhibitors of the Breast Cancer Resistance Protein (ABCG2)"],"prefix":"10.1007","author":[{"given":"Philipp","family":"Stockmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evamarie","family":"Hey-Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"850_CR1","first-page":"182","volume":"12","author":"S Ahmad","year":"2022","unstructured":"Ahmad S, Hassan MI, Gupta D et al (2022) Design and evaluation of pyrimidine derivatives as potent inhibitors of ABCG2, a breast cancer resistance protein. Biotech 12:182","journal-title":"Biotech"},{"key":"850_CR2","doi-asserted-by":"crossref","DOI":"10.3390\/ph18060895","volume":"18","author":"A Alhazza","year":"2025","unstructured":"Alhazza A, Oyegbesan A, Bousoik E, Montazeri Aliabadi H (2025) Multidrug resistance: are we still afraid of the big bad wolf. Pharmaceuticals 18:895","journal-title":"Pharmaceuticals"},{"key":"850_CR3","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1126\/science.1168750","volume":"323","author":"SG Aller","year":"2009","unstructured":"Aller SG, Yu J, Ward A et al (2009) Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science 323:1718\u20131722","journal-title":"Science"},{"key":"850_CR4","first-page":"5337","volume":"58","author":"R Allikmets","year":"1998","unstructured":"Allikmets R, Schriml LM, Hutchinson A et al (1998) A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res 58:5337\u20135339","journal-title":"Cancer Res"},{"key":"850_CR5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26136119","volume":"26","author":"L \u00c1lvarez-Fern\u00e1ndez","year":"2025","unstructured":"\u00c1lvarez-Fern\u00e1ndez L, Mill\u00e1n-Garc\u00eda A, Merino G, Blanco-Paniagua E (2025) ABCG2 transporter: from structure to function\u2014current insights and open questions. Int J Mol Sci 26:6119","journal-title":"Int J Mol Sci"},{"key":"850_CR6","doi-asserted-by":"crossref","first-page":"6343","DOI":"10.1038\/s41598-017-06445-z","volume":"7","author":"AC Alves","year":"2017","unstructured":"Alves AC, Magarkar A, Horta M et al (2017) Influence of doxorubicin on model cell membrane properties: insights from in vitro and in silico studies. Sci Rep 7:6343","journal-title":"Sci Rep"},{"key":"850_CR7","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11080370","volume":"11","author":"R Ancuceanu","year":"2019","unstructured":"Ancuceanu R, Dinu M, Dinu-Pirvu C et al (2019) Pharmacokinetics of B-ring unsubstituted flavones. Pharmaceutics 11:370","journal-title":"Pharmaceutics"},{"key":"850_CR8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112133","volume":"191","author":"F Antoni","year":"2020","unstructured":"Antoni F, Bause M, Scholler M et al (2020) Tariquidar-related triazoles as potent, selective and stable inhibitors of ABCG2 (BCRP). Eur J Med Chem 191:112133","journal-title":"Eur J Med Chem"},{"key":"850_CR9","doi-asserted-by":"crossref","first-page":"8416","DOI":"10.1002\/anie.201103051","volume":"50","author":"KAB Austin","year":"2011","unstructured":"Austin KAB, Herdtweck E, Bach T (2011) Intramolecular [2+2] photocycloaddition of substituted isoquinolones: enantioselectivity and kinetic resolution induced by a chiral template. Angew Chem Int Ed 50:8416\u20138419","journal-title":"Angew Chem Int Ed"},{"key":"850_CR10","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.1021\/jo100980p","volume":"75","author":"E Awuah","year":"2010","unstructured":"Awuah E, Capretta A (2010) Strategies and synthetic methods directed toward the preparation of libraries of substituted Isoquinolines. J Org Chem 75:5627\u20135634","journal-title":"J Org Chem"},{"key":"850_CR11","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1124\/dmd.122.001004","volume":"51","author":"SA Baril","year":"2023","unstructured":"Baril SA, Gose T, Schuetz JD (2023) How Cryo-EM has expanded our understanding of membrane transporters. Drug Metab Dispos 51:904\u2013922","journal-title":"Drug Metab Dispos"},{"key":"850_CR1003","doi-asserted-by":"crossref","unstructured":"Beck WT (1987) The cell biology of multiple drug resistance. Biochem Pharmacol 36(17):2879\u20132887","DOI":"10.1016\/0006-2952(87)90198-5"},{"key":"850_CR12","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.bmcl.2018.04.016","volume":"28","author":"MJ Bennett","year":"2018","unstructured":"Bennett MJ, Wu Y, Boloor A et al (2018) Design, synthesis and biological evaluation of novel 4-phenylisoquinolinone BET bromodomain inhibitors. Bioorg Med Chem Lett 28:1811\u20131816","journal-title":"Bioorg Med Chem Lett"},{"key":"850_CR13","doi-asserted-by":"crossref","first-page":"10893","DOI":"10.1021\/bi0503807","volume":"44","author":"A Bhatia","year":"2005","unstructured":"Bhatia A, Sch\u00e4fer H-J, Hrycyna CA (2005) Oligomerization of the human ABC transporter ABCG2: evaluation of the native protein and chimeric dimers. Biochemistry 44:10893\u201310904","journal-title":"Biochemistry"},{"key":"850_CR14","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev.biochem.71.102301.093055","volume":"71","author":"P Borst","year":"2002","unstructured":"Borst P, Elferink RO (2002) Mammalian ABC transporters in health and disease. Annu Rev Biochem 71:537\u2013592","journal-title":"Annu Rev Biochem"},{"key":"850_CR15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 74:229\u2013263","journal-title":"Cancer J Clin"},{"key":"850_CR16","volume":"271","author":"L Cai","year":"2024","unstructured":"Cai L, Xiong P-F, Li T et al (2024) Discovery of novel diaryl substituted isoquinolin-1(2H)-one derivatives as hypoxia-inducible factor-1 signaling inhibitors for the treatment of rheumatoid arthritis. Eur J Med Chem 271:116417","journal-title":"Eur J Med Chem"},{"key":"850_CR17","unstructured":"Cancer Today. https:\/\/gco.iarc.who.int\/today\/. Accessed 2 Jan 2026"},{"key":"850_CR18","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0031-9422(97)89023-1","volume":"45","author":"C-T Chang","year":"1997","unstructured":"Chang C-T, Doong S-L, Tsai I-L, Chen I-S (1997) Coumarins and anti-HBV constituents from Zanthoxylum schinifolium. Phytochemistry 45:1419\u20131422","journal-title":"Phytochemistry"},{"key":"850_CR19","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.omto.2022.01.005","volume":"24","author":"Y Chen","year":"2022","unstructured":"Chen Y, Du F, Tang L et al (2022) Carboranes as unique pharmacophores in antitumor medicinal chemistry. Mol Ther Oncol 24:400\u2013416","journal-title":"Mol Ther Oncol"},{"key":"850_CR20","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.21037\/tcr-24-1129","volume":"13","author":"R Chen","year":"2024","unstructured":"Chen R, Yu Y, Liu R, Chen Q (2024) Targeting breast cancer resistance protein (BCRP\/ABCG2) in cancer. Transl Cancer Res 13:6550\u20136564","journal-title":"Transl Cancer Res"},{"key":"850_CR21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0923-2508(01)01194-9","volume":"152","author":"E Dassa","year":"2001","unstructured":"Dassa E, Bouige P (2001) The ABC of ABCs: a phylogenetic and functional classification of ABC systems in living organisms. Res Microbiol 152:211\u2013229","journal-title":"Res Microbiol"},{"key":"850_CR22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106362","volume":"181","author":"F Deng","year":"2023","unstructured":"Deng F, Sj\u00f6stedt N, Santo M et al (2023) Novel inhibitors of breast cancer resistance protein (BCRP, ABCG2) among marketed drugs. Eur J Pharm Sci 181:106362","journal-title":"Eur J Pharm Sci"},{"key":"850_CR23","doi-asserted-by":"crossref","first-page":"11254","DOI":"10.1021\/acs.jmedchem.4c00809","volume":"67","author":"LG DeRatt","year":"2024","unstructured":"DeRatt LG, Zhang Z, Pietsch C et al (2024) Discovery of JNJ-74856665: a novel isoquinolinone DHODH inhibitor for the treatment of AML. J Med Chem 67:11254\u201311272","journal-title":"J Med Chem"},{"key":"850_CR24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010725","volume":"24","author":"S Di Micco","year":"2022","unstructured":"Di Micco S, Di Sarno V, Rossi M et al (2022) In Silico identification and in vitro evaluation of new ABCG2 transporter inhibitors as potential anticancer agents. Int J Mol Sci 24:725","journal-title":"Int J Mol Sci"},{"key":"850_CR25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbagen.2018.09.019","volume":"1863","author":"A Domenichini","year":"2019","unstructured":"Domenichini A, Adamska A, Falasca M (2019) ABC transporters as cancer drivers: potential functions in cancer development. Biochim Biophys Acta Gen Subj 1863:52\u201360","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"850_CR26","first-page":"288","volume":"12","author":"X-D Dong","year":"2024","unstructured":"Dong X-D, Lu Q, Li Y-D et al (2024) RN486, a Bruton\u2019s tyrosine kinase inhibitor, antagonizes multidrug resistance in ABCG2-overexpressing cancer cells. J Transl Int Med 12:288\u2013298","journal-title":"J Transl Int Med"},{"key":"850_CR27","doi-asserted-by":"crossref","first-page":"15665","DOI":"10.1073\/pnas.95.26.15665","volume":"95","author":"LA Doyle","year":"1998","unstructured":"Doyle LA, Yang W, Abruzzo LV et al (1998) A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA 95:15665\u201315670","journal-title":"Proc Natl Acad Sci USA"},{"key":"850_CR28","doi-asserted-by":"crossref","first-page":"9081","DOI":"10.1021\/jacs.6b05505","volume":"138","author":"RM Dziedzic","year":"2016","unstructured":"Dziedzic RM, Saleh LMA, Axtell JC et al (2016) B\u2013N, B\u2013O, and B\u2013CN bond formation via palladium-catalyzed cross-coupling of B-bromo-carboranes. J Am Chem Soc 138:9081\u20139084","journal-title":"J Am Chem Soc"},{"key":"850_CR29","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.1060","volume":"11","author":"R Elsby","year":"2023","unstructured":"Elsby R, Coghlan H, Edgerton J et al (2023) Mechanistic in vitro studies indicate that the clinical drug\u2013drug interactions between protease inhibitors and rosuvastatin are driven by inhibition of intestinal BCRP and hepatic OATP1B1 with minimal contribution from OATP1B3, NTCP and OAT3. Pharmacol Res Perspect 11:e01060","journal-title":"Pharmacol Res Perspect"},{"key":"850_CR30","volume":"14","author":"W Fan","year":"2024","unstructured":"Fan W, Shao K, Luo M (2024) Structural view of cryo-electron microscopy-determined ATP-binding cassette transporters in human multidrug resistance. Biomolecules 14:231","journal-title":"Biomolecules"},{"key":"850_CR31","first-page":"1068","volume":"8","author":"IF Faneyte","year":"2002","unstructured":"Faneyte IF, Kristel PMP, Maliepaard M et al (2002) Expression of the breast cancer resistance protein in breast cancer. Clin Cancer Res 8:1068\u20131074","journal-title":"Clin Cancer Res"},{"key":"850_CR32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1073\/pnas.84.1.265","volume":"84","author":"AT Fojo","year":"1987","unstructured":"Fojo AT, Ueda K, Slamon DJ et al (1987) Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 84:265\u2013269","journal-title":"Proc Natl Acad Sci USA"},{"key":"850_CR33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41573-023-00877-1","volume":"23","author":"A Galetin","year":"2024","unstructured":"Galetin A, Brouwer KLR, Tweedie D et al (2024) Membrane transporters in drug development and as determinants of precision medicine. Nat Rev Drug Discov 23:255\u2013280","journal-title":"Nat Rev Drug Discov"},{"key":"850_CR34","volume":"10","author":"M Galetti","year":"2015","unstructured":"Galetti M, Petronini PG, Fumarola C et al (2015) Effect of ABCG2\/BCRP expression on efflux and uptake of gefitinib in NSCLC cell lines. PLoS One 10:e0141795","journal-title":"PLoS One"},{"key":"850_CR35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1567201043480036","volume":"1","author":"H Glavinas","year":"2004","unstructured":"Glavinas H, Krajcsi P, Cserepes J, Sarkadi B (2004) The role of ABC transporters in drug resistance, metabolism and toxicity. Curr Drug Deliv 1:27\u201342","journal-title":"Curr Drug Deliv"},{"key":"850_CR36","first-page":"784","volume":"4","author":"J Goebel","year":"2021","unstructured":"Goebel J, Chmielewski J, Hrycyna CA (2021) The roles of the human ATP-binding cassette transporters P-glycoprotein and ABCG2 in multidrug resistance in cancer and at endogenous sites: future opportunities for structure-based drug design of inhibitors. Cancer Drug Resist 4:784\u2013804","journal-title":"Cancer Drug Resist"},{"key":"850_CR37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115070","volume":"248","author":"L Goracci","year":"2023","unstructured":"Goracci L, Nurisso A, Roussel E et al (2023) Inhibitors of ABCG2-mediated multidrug resistance: lead generation through computer-aided drug design. Eur J Med Chem 248:115070","journal-title":"Eur J Med Chem"},{"key":"850_CR38","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","volume":"2","author":"MM Gottesman","year":"2002","unstructured":"Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of ATP\u2013dependent transporters. Nat Rev Cancer 2:48\u201358","journal-title":"Nat Rev Cancer"},{"key":"850_CR39","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/nbt0609-546","volume":"27","author":"MM Gottesman","year":"2009","unstructured":"Gottesman MM, Ambudkar SV, Xia D (2009) Structure of a multidrug transporter. Nat Biotechnol 27:546\u2013547","journal-title":"Nat Biotechnol"},{"key":"850_CR40","volume-title":"Carboranes","author":"RN Grimes","year":"2016","unstructured":"Grimes RN (2016) Carboranes, 3rd edn. Academic, an imprint of Elsevier, Amsterdam\/Boston\/Heidelberg","edition":"3"},{"key":"850_CR41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.fitote.2014.01.019","volume":"94","author":"Y-Y Gu","year":"2014","unstructured":"Gu Y-Y, Liu L-P, Qin J et al (2014) Baicalein decreases side population proportion via inhibition of ABCG2 in multiple myeloma cell line RPMI 8226 in vitro. Fitoterapia 94:21\u201328","journal-title":"Fitoterapia"},{"key":"850_CR42","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1021\/ja01006a008","volume":"90","author":"MF Hawthorne","year":"1968","unstructured":"Hawthorne MF, Young DC, Andrews TD, Howe DV, Pilling RL, Pitts AD, Reintjes M, Warren LF, Wegner PA (1968) The chemistry of boranes. III. Carbon-containing boranes. J Am Chem Soc 90:879\u2013896","journal-title":"J Am Chem Soc"},{"key":"850_CR43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev.cb.08.110192.000435","volume":"8","author":"CF Higgins","year":"1992","unstructured":"Higgins CF (1992) ABC transporters: from microorganisms to man. Annu Rev Cell Dev Biol 8:67\u2013113","journal-title":"Annu Rev Cell Dev Biol"},{"key":"850_CR44","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/cancers6031769","volume":"6","author":"G Housman","year":"2014","unstructured":"Housman G, Byler S, Heerboth S et al (2014) Drug resistance in cancer: an overview. Cancers 6:1769\u20131792","journal-title":"Cancers"},{"key":"850_CR45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1124\/jpet.107.132225","volume":"328","author":"M Huls","year":"2009","unstructured":"Huls M, Russel FGM, Masereeuw R (2009) The role of ATP binding cassette transporters in tissue defense and organ regeneration. J Pharmacol Exp Ther 328:3\u20139","journal-title":"J Pharmacol Exp Ther"},{"key":"850_CR1001","unstructured":"Inaba M, Johnson RK (1977) Decreased retention of actinomycin D as the basis for cross-resistance in anthracycline-resistant sublines of P388 leukemia. Cancer Res 37(12):4629\u20134634"},{"key":"850_CR1002","unstructured":"Inaba M, Kobayashi H, Sakurai Y, Johnson RK (1979) Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia. Cancer Res 39:2200\u20132203"},{"key":"850_CR47","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41594-018-0049-1","volume":"25","author":"SM Jackson","year":"2018","unstructured":"Jackson SM, Manolaridis I, Kowal J et al (2018) Structural basis of small-molecule inhibition of human multidrug transporter ABCG2. Nat Struct Mol Biol 25:333\u2013340","journal-title":"Nat Struct Mol Biol"},{"key":"850_CR48","first-page":"988","volume":"56","author":"G Jedlitschky","year":"1996","unstructured":"Jedlitschky G, Leier I, Buchholz U et al (1996) Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res 56:988\u2013994","journal-title":"Cancer Res"},{"key":"850_CR1000","doi-asserted-by":"crossref","unstructured":"Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455(1):152\u2013162","DOI":"10.1016\/0005-2736(76)90160-7"},{"key":"850_CR49","doi-asserted-by":"crossref","first-page":"6766","DOI":"10.1016\/j.bmcl.2012.08.024","volume":"22","author":"K Juvale","year":"2012","unstructured":"Juvale K, Wiese M (2012) 4-Substituted-2-phenylquinazolines as inhibitors of BCRP. Bioorg Med Chem Lett 22:6766\u20136769","journal-title":"Bioorg Med Chem Lett"},{"key":"850_CR50","doi-asserted-by":"crossref","first-page":"7858","DOI":"10.1016\/j.bmc.2013.10.007","volume":"21","author":"K Juvale","year":"2013","unstructured":"Juvale K, Gallus J, Wiese M (2013a) Investigation of quinazolines as inhibitors of breast cancer resistance protein (ABCG2). Bioorg Med Chem 21:7858\u20137873","journal-title":"Bioorg Med Chem"},{"key":"850_CR51","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejmech.2013.06.035","volume":"67","author":"K Juvale","year":"2013","unstructured":"Juvale K, Stefan K, Wiese M (2013b) Synthesis and biological evaluation of flavones and benzoflavones as inhibitors of BCRP\/ABCG2. Eur J Med Chem 67:115\u2013126","journal-title":"Eur J Med Chem"},{"key":"850_CR52","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.canlet.2016.03.030","volume":"376","author":"C Karthikeyan","year":"2016","unstructured":"Karthikeyan C, Malla R, Ashby CR et al (2016) Pyrimido[1\u2033,2\u2033:1,5]pyrazolo[3,4-b]quinolines: novel compounds that reverse ABCG2-mediated resistance in cancer cells. Cancer Lett 376:118\u2013126","journal-title":"Cancer Lett"},{"key":"850_CR53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/476974","volume":"2014","author":"K Katayama","year":"2014","unstructured":"Katayama K, Noguchi K, Sugimoto Y (2014) Regulations of P-glycoprotein\/ABCB1\/MDR1 in human cancer cells. New J Sci 2014:1\u201310","journal-title":"New J Sci"},{"key":"850_CR54","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/s41598-020-79892-w","volume":"11","author":"DH Kita","year":"2021","unstructured":"Kita DH, Guragossian N, Zattoni IF et al (2021) Mechanistic basis of breast cancer resistance protein inhibition by new indeno[1,2-b]indoles. Sci Rep 11:1788","journal-title":"Sci Rep"},{"key":"850_CR55","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ejmech.2018.01.012","volume":"146","author":"SC K\u00f6hler","year":"2018","unstructured":"K\u00f6hler SC, Vahdati S, Scholz MS, Wiese M (2018) Structure activity relationships, multidrug resistance reversal and selectivity of heteroarylphenyl ABCG2 inhibitors. Eur J Med Chem 146:483\u2013500","journal-title":"Eur J Med Chem"},{"key":"850_CR56","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1007\/s00018-009-0064-9","volume":"66","author":"V Kos","year":"2009","unstructured":"Kos V, Ford RC (2009) The ATP-binding cassette family: a structural perspective. Cell Mol Life Sci 66:3111\u20133126","journal-title":"Cell Mol Life Sci"},{"key":"850_CR57","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ejmech.2016.03.067","volume":"117","author":"S Kraege","year":"2016","unstructured":"Kraege S, Stefan K, Juvale K et al (2016) The combination of quinazoline and chalcone moieties leads to novel potent heterodimeric modulators of breast cancer resistance protein (BCRP\/ABCG2). Eur J Med Chem 117:212\u2013229","journal-title":"Eur J Med Chem"},{"key":"850_CR58","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1021\/acs.jmedchem.6b00330","volume":"59","author":"MK Krapf","year":"2016","unstructured":"Krapf MK, Wiese M (2016) Synthesis and biological evaluation of 4-Anilino-quinazolines and -quinolines as inhibitors of breast cancer resistance protein (ABCG2). J Med Chem 59:5449\u20135461","journal-title":"J Med Chem"},{"key":"850_CR59","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ejmech.2017.08.020","volume":"139","author":"MK Krapf","year":"2017","unstructured":"Krapf MK, Gallus J, Wiese M (2017a) Synthesis and biological investigation of 2,4-substituted quinazolines as highly potent inhibitors of breast cancer resistance protein (ABCG2). Eur J Med Chem 139:587\u2013611","journal-title":"Eur J Med Chem"},{"key":"850_CR60","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1021\/acs.jmedchem.7b00441","volume":"60","author":"MK Krapf","year":"2017","unstructured":"Krapf MK, Gallus J, Wiese M (2017b) 4-Anilino-2-pyridylquinazolines and -pyrimidines as highly potent and nontoxic inhibitors of breast cancer resistance protein (ABCG2). J Med Chem 60:4474\u20134495","journal-title":"J Med Chem"},{"key":"850_CR61","doi-asserted-by":"crossref","first-page":"7952","DOI":"10.1021\/acs.jmedchem.8b01011","volume":"61","author":"MK Krapf","year":"2018","unstructured":"Krapf MK, Gallus J, Namasivayam V, Wiese M (2018) 2,4,6-substituted quinazolines with extraordinary inhibitory potency toward ABCG2. J Med Chem 61:7952\u20137976","journal-title":"J Med Chem"},{"key":"850_CR62","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ejmech.2018.10.026","volume":"161","author":"MK Krapf","year":"2019","unstructured":"Krapf MK, Gallus J, Spindler A, Wiese M (2019) Synthesis and biological evaluation of quinazoline derivatives \u2013 a SAR study of novel inhibitors of ABCG2. Eur J Med Chem 161:506\u2013525","journal-title":"Eur J Med Chem"},{"key":"850_CR63","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202100588","volume":"17","author":"R Kuhnert","year":"2022","unstructured":"Kuhnert R, Kuhnert L, S\u00e1rosi M et al (2022) Borcalein: a carborane-based analogue of baicalein with 12-lipoxygenase-independent toxicity. ChemMedChem 17:e202100588","journal-title":"ChemMedChem"},{"key":"850_CR64","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/1878-0261.13527","volume":"18","author":"L Kuhnert","year":"2024","unstructured":"Kuhnert L, Kuhnert R, S\u00e1rosi MB et al (2024) Enhanced reversal of ABCG2-mediated drug resistance by replacing a phenyl ring in baicalein with a meta-carborane. Mol Oncol 18:280\u2013290","journal-title":"Mol Oncol"},{"key":"850_CR65","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202500708","volume":"21","author":"L Kuhnert","year":"2026","unstructured":"Kuhnert L, Stockmann P, L\u00f6nnecke P et al (2026) Polymethoxylated N-carboranyl isoquinolinones: a new scaffold for ABCG2 inhibitors. ChemMedChem 21:e202500708","journal-title":"ChemMedChem"},{"key":"850_CR66","doi-asserted-by":"crossref","first-page":"eabn2707","DOI":"10.1126\/scisignal.abn2707","volume":"15","author":"AM Kurimchak","year":"2022","unstructured":"Kurimchak AM, Herrera-Mont\u00e1vez C, Montserrat-Sangr\u00e0 S et al (2022) The drug efflux pump MDR1 promotes intrinsic and acquired resistance to PROTACs in cancer cells. Sci Signal 15:eabn2707","journal-title":"Sci Signal"},{"key":"850_CR67","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.4155\/fmc.13.71","volume":"5","author":"F Lecerf-Schmidt","year":"2013","unstructured":"Lecerf-Schmidt F, Peres B, Valdameri G et al (2013) ABCG2: recent discovery of potent and highly selective inhibitors. Future Med Chem 5:1037\u20131045","journal-title":"Future Med Chem"},{"key":"850_CR68","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1039\/D5MD00025D","volume":"16","author":"JW Lee","year":"2025","unstructured":"Lee JW, Im CG, Lee JM et al (2025a) Discovery of isoquinoline-tethered quinazoline derivatives with enhanced HER2 inhibition over EGFR. RSC Med Chem 16:2174\u20132189","journal-title":"RSC Med Chem"},{"key":"850_CR69","doi-asserted-by":"crossref","first-page":"28558","DOI":"10.1038\/s41598-025-13908-1","volume":"15","author":"K-R Lee","year":"2025","unstructured":"Lee K-R, Kang M-J, Kim MJ et al (2025b) Inhibition of breast cancer resistance protein by flavonols: in vitro, in vivo, and in silico implications of the interactions. Sci Rep 15:28558","journal-title":"Sci Rep"},{"key":"850_CR70","doi-asserted-by":"crossref","first-page":"27807","DOI":"10.1016\/S0021-9258(18)46856-1","volume":"269","author":"I Leier","year":"1994","unstructured":"Leier I, Jedlitschky G, Buchholz U et al (1994) The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J Biol Chem 269:27807\u201327810","journal-title":"J Biol Chem"},{"key":"850_CR71","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jpba.2009.04.028","volume":"50","author":"C Li","year":"2009","unstructured":"Li C, Zhou L, Lin G, Zuo Z (2009) Contents of major bioactive flavones in proprietary traditional Chinese medicine products and reference herb of Scutellariae radix. J Pharm Biomed Anal 50:298\u2013306","journal-title":"J Pharm Biomed Anal"},{"key":"850_CR72","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1021\/acs.jmedchem.2c01862","volume":"66","author":"H Li","year":"2023","unstructured":"Li H, Zhang S-L, Jia Y-H et al (2023) Imidazo[1,2-a]Pyridine derivatives as novel dual-target inhibitors of ABCB1 and ABCG2 for reversing multidrug resistance. J Med Chem 66:2804\u20132831","journal-title":"J Med Chem"},{"key":"850_CR73","volume":"228","author":"Y Li","year":"2024","unstructured":"Li Y, Guo F, Wang W et al (2024) Marein, a novel natural product for restoring chemo-sensitivity to cancer cells through competitive inhibition of ABCG2 function. Biochem Pharmacol 228:116219","journal-title":"Biochem Pharmacol"},{"key":"850_CR74","volume":"180","author":"B-H Lin","year":"2024","unstructured":"Lin B-H, Li Y-C, Murakami M et al (2024) Epertinib counteracts multidrug resistance in cancer cells by antagonizing the drug efflux function of ABCB1 and ABCG2. Biomed Pharmacother 180:117542","journal-title":"Biomed Pharmacother"},{"key":"850_CR75","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1152\/physiol.00046.2006","volume":"22","author":"KJ Linton","year":"2007","unstructured":"Linton KJ (2007) Structure and function of ABC transporters. Physiology 22:122\u2013130","journal-title":"Physiology"},{"key":"850_CR76","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1242\/jcs.113.11.2011","volume":"113","author":"T Litman","year":"2000","unstructured":"Litman T, Brangi M, Hudson E et al (2000) The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2). J Cell Sci 113:2011\u20132021","journal-title":"J Cell Sci"},{"key":"850_CR77","volume":"17","author":"H Liu","year":"2016","unstructured":"Liu H, Dong Y, Gao Y et al (2016) The fascinating effects of baicalein on cancer: a review. IJMS 17:1681","journal-title":"IJMS"},{"key":"850_CR78","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/path.1706","volume":"205","author":"D Longley","year":"2005","unstructured":"Longley D, Johnston P (2005) Molecular mechanisms of drug resistance. J Pathol 205:275\u2013292","journal-title":"J Pathol"},{"key":"850_CR79","doi-asserted-by":"crossref","first-page":"339","DOI":"10.15171\/apb.2017.041","volume":"7","author":"B Mansoori","year":"2017","unstructured":"Mansoori B, Mohammadi A, Davudian S et al (2017) The different mechanisms of cancer drug resistance: a brief review. Adv Pharm Bull 7:339\u2013348","journal-title":"Adv Pharm Bull"},{"key":"850_CR80","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1208\/s12248-014-9668-6","volume":"17","author":"Q Mao","year":"2015","unstructured":"Mao Q, Unadkat JD (2015) Role of the breast cancer resistance protein (BCRP\/ABCG2) in drug transport\u2014an update. AAPS J 17:65\u201382","journal-title":"AAPS J"},{"key":"850_CR81","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41570-022-00400-x","volume":"6","author":"A Marfavi","year":"2022","unstructured":"Marfavi A, Kavianpour P, Rendina LM (2022) Carboranes in drug discovery, chemical biology and molecular imaging. Nat Rev Chem 6:486\u2013504","journal-title":"Nat Rev Chem"},{"key":"850_CR82","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.addr.2008.07.004","volume":"61","author":"CA McDevitt","year":"2009","unstructured":"McDevitt CA, Collins R, Kerr ID, Callaghan R (2009) Purification and structural analyses of ABCG2. Adv Drug Deliv Rev 61:57\u201365","journal-title":"Adv Drug Deliv Rev"},{"key":"850_CR83","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nrc1886","volume":"6","author":"P Mehlen","year":"2006","unstructured":"Mehlen P, Puisieux A (2006) Metastasis: a question of life or death. Nat Rev Cancer 6:449\u2013458","journal-title":"Nat Rev Cancer"},{"key":"850_CR84","first-page":"1","volume":"3","author":"W Mo","year":"2011","unstructured":"Mo W, Zhang J-T (2011) Human ABCG2: structure, function, and its role in multidrug resistance. Int J Biochem Mol Biol 3:1\u201327","journal-title":"Int J Biochem Mol Biol"},{"key":"850_CR85","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114628","volume":"241","author":"M Moinul","year":"2022","unstructured":"Moinul M, Amin SA, Jha T, Gayen S (2022) Updated chemical scaffolds of ABCG2 inhibitors and their structure-inhibition relationships for future development. Eur J Med Chem 241:114628","journal-title":"Eur J Med Chem"},{"key":"850_CR86","doi-asserted-by":"crossref","first-page":"13033","DOI":"10.1073\/pnas.91.26.13033","volume":"91","author":"M M\u00fcller","year":"1994","unstructured":"M\u00fcller M, Meijer C, Zaman GJ et al (1994) Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc Natl Acad Sci USA 91:13033\u201313037","journal-title":"Proc Natl Acad Sci USA"},{"key":"850_CR87","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1021\/acs.jmedchem.0c02199","volume":"64","author":"V Namasivayam","year":"2021","unstructured":"Namasivayam V, Silbermann K, Wiese M et al (2021) C@PA: computer-aided pattern analysis to predict multitarget ABC transporter inhibitors. J Med Chem 64:3350\u20133366","journal-title":"J Med Chem"},{"key":"850_CR88","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.addr.2008.10.004","volume":"61","author":"E Nicolle","year":"2009","unstructured":"Nicolle E, Boumendjel A, Macalou S et al (2009) QSAR analysis and molecular modeling of ABCG2-specific inhibitors. Adv Drug Deliv Rev 61:34\u201346","journal-title":"Adv Drug Deliv Rev"},{"key":"850_CR89","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1038\/s41467-020-16155-2","volume":"11","author":"BJ Orlando","year":"2020","unstructured":"Orlando BJ, Liao M (2020) ABCG2 transports anticancer drugs via a closed-to-open switch. Nat Commun 11:2264","journal-title":"Nat Commun"},{"key":"850_CR90","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1021\/mp300547h","volume":"10","author":"Y Pan","year":"2013","unstructured":"Pan Y, Chothe PP, Swaan PW (2013) Identification of novel breast cancer resistance protein (BCRP) inhibitors by virtual screening. Mol Pharm 10:1236\u20131248","journal-title":"Mol Pharm"},{"key":"850_CR91","doi-asserted-by":"crossref","DOI":"10.3390\/ph16111582","volume":"16","author":"S Paskas","year":"2023","unstructured":"Paskas S, Stockmann P, Mijatovi\u0107 S et al (2023) Carborane-based ABCG2-inhibitors sensitize ABC-(over)expressing cancer cell lines for doxorubicin and cisplatin. Pharmaceuticals 16:1582","journal-title":"Pharmaceuticals"},{"key":"850_CR92","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/med.21428","volume":"37","author":"D Pe\u00f1a-Sol\u00f3rzano","year":"2017","unstructured":"Pe\u00f1a-Sol\u00f3rzano D, Stark SA, K\u00f6nig B et al (2017) ABCG2\/BCRP: specific and nonspecific modulators. Med Res Rev 37:987\u20131050","journal-title":"Med Res Rev"},{"key":"850_CR93","volume":"26","author":"A Pfeiffer","year":"2025","unstructured":"Pfeiffer A, Di Leo L, Bechmann MB et al (2025) Inhibition of ABCG2 by SCO-101 enhances chemotherapy efficacy in cancer. IJMS 26:3790","journal-title":"IJMS"},{"key":"850_CR94","first-page":"5850","volume":"58","author":"SK Rabindran","year":"1998","unstructured":"Rabindran SK, He H, Singh M et al (1998) Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C. Cancer Res 58:5850\u20135858","journal-title":"Cancer Res"},{"key":"850_CR95","first-page":"47","volume":"60","author":"SK Rabindran","year":"2000","unstructured":"Rabindran SK, Ross DD, Doyle LA et al (2000) Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein. Cancer Res 60:47\u201350","journal-title":"Cancer Res"},{"key":"850_CR96","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/cpt.3657","volume":"118","author":"AM Riselli","year":"2025","unstructured":"Riselli AM, Yee SW, Yang J et al (2025) Identification and clinical evaluation of potential biomarkers for breast cancer resistance protein (BCRP \/ ABCG2). Clin Pharma Ther 118:177\u2013189","journal-title":"Clin Pharma Ther"},{"key":"850_CR97","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/sj.bjc.6601370","volume":"89","author":"RW Robey","year":"2003","unstructured":"Robey RW, Honjo Y, Morisaki K et al (2003) Mutations at amino acid 482 in the ABCG2 gene affect substrate and antagonist specificity. Br J Cancer 89:1971\u20131978","journal-title":"Br J Cancer"},{"key":"850_CR98","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41568-018-0005-8","volume":"18","author":"RW Robey","year":"2018","unstructured":"Robey RW, Pluchino KM, Hall MD et al (2018) Revisiting the role of ABC transporters in multidrug-resistant cancer. Nat Rev Cancer 18:452\u2013464","journal-title":"Nat Rev Cancer"},{"key":"850_CR99","doi-asserted-by":"crossref","first-page":"16076","DOI":"10.1074\/jbc.M100176200","volume":"276","author":"MF Rosenberg","year":"2001","unstructured":"Rosenberg MF, Mao Q, Holzenburg A et al (2001) The structure of the multidrug resistance protein 1 (MRP1\/ABCC1): crystallization and single-particle analysis. J Biol Chem 276:16076\u201316082","journal-title":"J Biol Chem"},{"key":"850_CR100","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1074\/jbc.M410296200","volume":"280","author":"MF Rosenberg","year":"2005","unstructured":"Rosenberg MF, Callaghan R, Modok S et al (2005) Three-dimensional structure of P-glycoprotein: the transmembrane regions adopt an asymmetric configuration in the nucleotide-bound state. J Biol Chem 280:2857\u20132862","journal-title":"J Biol Chem"},{"key":"850_CR101","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/17425255.2019.1591373","volume":"15","author":"Z Safar","year":"2019","unstructured":"Safar Z, Kis E, Erdo F et al (2019) ABCG2\/BCRP: variants, transporter interaction profile of substrates and inhibitors. Expert Opin Drug Metab Toxicol 15:313\u2013328","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"850_CR102","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1152\/physrev.00037.2005","volume":"86","author":"B Sarkadi","year":"2006","unstructured":"Sarkadi B, Homolya L, Szak\u00e1cs G, V\u00e1radi A (2006) Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system. Physiol Rev 86:1179\u20131236","journal-title":"Physiol Rev"},{"key":"850_CR103","doi-asserted-by":"crossref","first-page":"7035","DOI":"10.1021\/cr200038x","volume":"111","author":"M Scholz","year":"2011","unstructured":"Scholz M, Hey-Hawkins E (2011) Carbaboranes as pharmacophores: properties, synthesis, and application strategies. Chem Rev 111:7035\u20137062","journal-title":"Chem Rev"},{"key":"850_CR104","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2020.131150","volume":"76","author":"R Sch\u00fctz","year":"2020","unstructured":"Sch\u00fctz R, Schmidt S, Bracher F (2020) A versatile approach to 1-oxo-, 1-oxo-3,4-dihydro- and 1,3,4-trioxo isoquinoline alkaloids and first total synthesis of the dimeric 1-oxoisoquinoline alkaloids berbanine and berbidine. Tetrahedron 76:131150","journal-title":"Tetrahedron"},{"key":"850_CR105","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2217\/pgs-2021-0116","volume":"22","author":"P Sharma","year":"2021","unstructured":"Sharma P, Singh N, Sharma S (2021) ATP binding cassette transporters and cancer: revisiting their controversial role. Pharmacogenomics 22:1211\u20131235","journal-title":"Pharmacogenomics"},{"key":"850_CR106","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1042\/bse0500161","volume":"50","author":"FJ Sharom","year":"2011","unstructured":"Sharom FJ (2011) The P-glycoprotein multidrug transporter. Essays Biochem 50:161\u2013178","journal-title":"Essays Biochem"},{"key":"850_CR107","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10637-025-01526-7","volume":"43","author":"S Shim","year":"2025","unstructured":"Shim S, Reinacher-Schick A, Kraeft A-L et al (2025) PANTAX: a phase Ib clinical trial of the efflux pump inhibitor SCO-101 in combination with gemcitabine and nab-paclitaxel in non-resectable or metastatic pancreatic cancer. Investig New Drugs 43:337\u2013347","journal-title":"Investig New Drugs"},{"key":"850_CR108","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.drup.2012.01.005","volume":"15","author":"S Shukla","year":"2012","unstructured":"Shukla S, Chen Z-S, Ambudkar SV (2012) Tyrosine kinase inhibitors as modulators of ABC transporter-mediated drug resistance. Drug Resist Updat 15:70\u201380","journal-title":"Drug Resist Updat"},{"key":"850_CR109","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113045","volume":"212","author":"K Silbermann","year":"2021","unstructured":"Silbermann K, Li J, Namasivayam V et al (2021) Rational drug design of 6-substituted 4-anilino-2-phenylpyrimidines for exploration of novel ABCG2 binding site. Eur J Med Chem 212:113045","journal-title":"Eur J Med Chem"},{"key":"850_CR110","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1124\/mol.113.088609","volume":"84","author":"AE Stacy","year":"2013","unstructured":"Stacy AE, Jansson PJ, Richardson DR (2013) Molecular pharmacology of ABCG2 and its role in chemoresistance. Mol Pharmacol 84:655\u2013669","journal-title":"Mol Pharmacol"},{"key":"850_CR111","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1039\/C9CS00197B","volume":"48","author":"P Stockmann","year":"2019","unstructured":"Stockmann P, Gozzi M, Kuhnert R et al (2019) New keys for old locks: carborane-containing drugs as platforms for mechanism-based therapies. Chem Soc Rev 48:3497\u20133512","journal-title":"Chem Soc Rev"},{"key":"850_CR112","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15010241","volume":"15","author":"P Stockmann","year":"2023","unstructured":"Stockmann P, Kuhnert L, Leinung W et al (2023a) The more the better\u2014investigation of polymethoxylated N-carboranyl quinazolines as novel hybrid breast cancer resistance protein inhibitors. Pharmaceutics 15:241","journal-title":"Pharmaceutics"},{"key":"850_CR113","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202300094","volume":"18","author":"P Stockmann","year":"2023","unstructured":"Stockmann P, Kuhnert L, Z\u00f6rner L et al (2023b) 2-Carboranylquinazoline: the path to an ABCG2 inhibitor. ChemMedChem 18:e202300094","journal-title":"ChemMedChem"},{"key":"850_CR114","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202300506","volume":"19","author":"P Stockmann","year":"2024","unstructured":"Stockmann P, Kuhnert L, Leinung W et al (2024) Carboranes as potent phenyl mimetics: a comparative study on the reversal of ABCG2-mediated drug resistance by carboranylquinazolines and their organic isosteres. ChemMedChem 19:e202300506","journal-title":"ChemMedChem"},{"key":"850_CR115","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.drudis.2007.12.010","volume":"13","author":"G Szak\u00e1cs","year":"2008","unstructured":"Szak\u00e1cs G, V\u00e1radi A, \u00d6zvegy-Laczka C, Sarkadi B (2008) The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME\u2013Tox). Drug Discov Today 13:379\u2013393","journal-title":"Drug Discov Today"},{"key":"850_CR116","doi-asserted-by":"publisher","unstructured":"Taylor NMI, Manolaridis I, Jackson SM et al (2017) Structure of an ABC transporter: complete structure. 5nj3. https:\/\/doi.org\/10.2210\/pdb5NJ3\/pdb","DOI":"10.2210\/pdb5NJ3\/pdb"},{"key":"850_CR117","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00210-021-02112-3","volume":"394","author":"D Theile","year":"2021","unstructured":"Theile D, Wizgall P (2021) Acquired ABC-transporter overexpression in cancer cells: transcriptional induction or Darwinian selection? Arch Pharmacol 394:1621\u20131632","journal-title":"Arch Pharmacol"},{"key":"850_CR118","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00208","volume":"10","author":"Y Toyoda","year":"2019","unstructured":"Toyoda Y, Takada T, Suzuki H (2019) Inhibitors of human ABCG2: from technical background to recent updates with clinical implications. Front Pharmacol 10:208","journal-title":"Front Pharmacol"},{"key":"850_CR119","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15041259","volume":"15","author":"G Valdameri","year":"2023","unstructured":"Valdameri G, Kita DH, Dutra JDP et al (2023) Characterization of potent ABCG2 inhibitor derived from Chromone: from the mechanism of inhibition to human extracellular vesicles for drug delivery. Pharmaceutics 15:1259","journal-title":"Pharmaceutics"},{"key":"850_CR120","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0960-894X(00)00588-6","volume":"11","author":"A van Loevezijn","year":"2001","unstructured":"van Loevezijn A, Allen JD, Schinkel AH, Koomen G-J (2001) Inhibition of BCRP-mediated drug efflux by fumitremorgin-type indolyl diketopiperazines. Bioorg Med Chem Lett 11:29\u201332","journal-title":"Bioorg Med Chem Lett"},{"key":"850_CR121","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1021\/jm000002u","volume":"43","author":"JE Van Muijlwijk-Koezen","year":"2000","unstructured":"Van Muijlwijk-Koezen JE, Timmerman H, Van Der Goot H et al (2000) Isoquinoline and quinazoline urea analogues as antagonists for the human adenosine A3 receptor. J Med Chem 43:2227\u20132238","journal-title":"J Med Chem"},{"key":"850_CR122","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1208\/s12248-024-00950-6","volume":"26","author":"DA Volpe","year":"2024","unstructured":"Volpe DA (2024) Knockout transporter cell lines to assess substrate potential towards efflux transporters. AAPS J 26:79","journal-title":"AAPS J"},{"key":"850_CR123","doi-asserted-by":"crossref","first-page":"13778","DOI":"10.1021\/bi801644v","volume":"47","author":"H Wang","year":"2008","unstructured":"Wang H, Lee E-W, Cai X et al (2008) Membrane topology of the human breast cancer resistance protein (BCRP\/ABCG2) determined by epitope insertion and immunofluorescence. Biochemistry 47:13778\u201313787","journal-title":"Biochemistry"},{"key":"850_CR124","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/jebm.12434","volume":"14","author":"J Wang","year":"2021","unstructured":"Wang J, Wu Z, Yang Y et al (2021) ATP-binding cassette (ABC) transporters in cancer: a review of recent updates. J Evid Based Med 14:232\u2013256","journal-title":"J Evid Based Med"},{"key":"850_CR46","volume-title":"World cancer report: cancer research for cancer prevention","year":"2020","unstructured":"Wild C, Weiderpass E, Stewart BW, International Agency for Research on Cancer (eds) (2020) World cancer report: cancer research for cancer prevention. International Agency for Research on Cancer, Lyon"},{"key":"850_CR125","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.canlet.2014.03.013","volume":"347","author":"Q Wu","year":"2014","unstructured":"Wu Q, Yang Z, Nie Y et al (2014) Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches. Cancer Lett 347:159\u2013166","journal-title":"Cancer Lett"},{"key":"850_CR126","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1124\/mol.112.079129","volume":"82","author":"CQ Xia","year":"2012","unstructured":"Xia CQ, Smith PG (2012) Drug efflux transporters and multidrug resistance in acute leukemia: therapeutic impact and novel approaches to mediation. Mol Pharmacol 82:1008\u20131021","journal-title":"Mol Pharmacol"},{"key":"850_CR127","volume":"12","author":"H Xiao","year":"2021","unstructured":"Xiao H, Zheng Y, Ma L et al (2021) Clinically-relevant ABC transporter for anti-cancer drug resistance. Front Pharmacol 12:648407","journal-title":"Front Pharmacol"},{"key":"850_CR128","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.omto.2019.12.007","volume":"16","author":"L Xu","year":"2020","unstructured":"Xu L, Huang J, Liu J et al (2020) CM082 enhances the efficacy of chemotherapeutic drugs by inhibiting the drug efflux function of ABCG2. Mol Ther Oncol 16:100\u2013110","journal-title":"Mol Ther Oncol"},{"key":"850_CR129","volume":"135","author":"G-J Ye","year":"2023","unstructured":"Ye G-J, Cai C-Y, Dong X-D et al (2023) Design, synthesis, and biological evaluation of phenylurea indole derivatives as ABCG2 inhibitors. Bioorg Chem 135:106481","journal-title":"Bioorg Chem"},{"key":"850_CR130","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1021\/acschembio.4c00353","volume":"19","author":"Q Yu","year":"2024","unstructured":"Yu Q, Dehghani-Ghahnaviyeh S, Rasouli A et al (2024) Modulation of ABCG2 transporter activity by Ko143 derivatives. ACS Chem Biol 19:2304\u20132313","journal-title":"ACS Chem Biol"},{"key":"850_CR131","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1208\/s12248-011-9277-6","volume":"13","author":"L Zhang","year":"2011","unstructured":"Zhang L, Li C, Lin G et al (2011) Hepatic metabolism and disposition of baicalein via the coupling of conjugation enzymes and transporters\u2014in vitro and in vivo evidences. AAPS J 13:378","journal-title":"AAPS J"},{"key":"850_CR132","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jff.2018.12.037","volume":"54","author":"B Zhang","year":"2019","unstructured":"Zhang B, Dong Y, Yu N et al (2019) Intestinal metabolism of baicalein after oral administration in mice: pharmacokinetics and mechanisms. J Funct Foods 54:53\u201363","journal-title":"J Funct Foods"},{"key":"850_CR133","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/jphp.13129","volume":"71","author":"T Zhao","year":"2019","unstructured":"Zhao T, Tang H, Xie L et al (2019) Scutellaria baicalensis Georgi. (Lamiaceae): a review of its traditional uses, botany, phytochemistry, pharmacology and toxicology. J Pharm Pharmacol 71:1353\u20131369","journal-title":"J Pharm Pharmacol"},{"key":"850_CR134","volume":"138","author":"X Zhou","year":"2021","unstructured":"Zhou X, Fu L, Wang P et al (2021) Drug-herb interactions between Scutellaria baicalensis and pharmaceutical drugs: insights from experimental studies, mechanistic actions to clinical applications. Biomed Pharmacother 138:111445","journal-title":"Biomed Pharmacother"},{"key":"850_CR135","doi-asserted-by":"crossref","first-page":"8578","DOI":"10.1021\/acs.jmedchem.9b00963","volume":"62","author":"X Zhu","year":"2019","unstructured":"Zhu X, Wong ILK, Chan K-F et al (2019) Triazole bridged flavonoid dimers as potent, nontoxic, and highly selective breast cancer resistance protein (BCRP\/ABCG2) inhibitors. J Med Chem 62:8578\u20138608","journal-title":"J Med Chem"},{"key":"850_CR136","volume":"259","author":"J Zhu","year":"2023","unstructured":"Zhu J, Lei S, Lu J et al (2023) Metabolism-guided development of Ko143 analogs as ABCG2 inhibitors. Eur J Med Chem 259:115666","journal-title":"Eur J Med Chem"}],"container-title":["Handbook of Experimental Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2026_850","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:01:59Z","timestamp":1790672519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/164_2026_850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":140,"URL":"https:\/\/doi.org\/10.1007\/164_2026_850","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"30 September 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}